Maryland · 2025 Regular Session · Bill
SB 921: Health Insurance - Step Therapy or Fail-First Protocols - Drugs to Treat Associated Conditions of Advanced Metastatic Cancer
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 921 is a bill introduced in the Maryland Senate on February 3, 2025. According to its official title, it concerns: Health Insurance - Step Therapy or Fail-First Protocols - Drugs to Treat Associated Conditions of Advanced Metastatic Cancer. Primary sponsor: Dawn Gile (Democratic). Most recent recorded action (May 20, 2025): Approved by the Governor - Chapter 707.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Dawn Gile | Primary sponsor | Democratic | Senate | 33 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Approved by the Governor - Chapter 707
- Returned Passed
- Third Reading Passed
- Favorable Adopted Second Reading Passed
- Favorable Report by Health and Government Operations
- Rereferred to Health and Government Operations
- Referred Rules and Executive Nominations
- Third Reading Passed
- Second Reading Passed with Amendments
- Favorable with Amendments {
- Favorable with Amendments Report by Finance
- Hearing 2/26 at 1:00 p.m.
Showing 12 most recent of 13 actions. Full history